跳至主要内容
临床试验/JPRN-UMIN000044137
JPRN-UMIN000044137招募中未知

Prospective observational study on gut microbiome as a novel biomarker for patients with cancer cachexia treated with anamorelin - Exploratory analysis of gut microbiome in patients with cancer cachexia

Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital0 个研究点目标入组 120 人开始时间: 2021年5月10日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Subjects who could not give their consent. 2. Subjects with illnesses or conditions that interfere with their capacity to understand, follow and/or comply with study procedures.

研究者

发起方
Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital

相似试验